Accelerating Belgian health-tech & biopharma innovation

About BioWin
iStock-1093656424-web5

See what’s happening in Wallonia, Belgium

Latest news & events

Learn more
iStock-576919844

Call 46 for collaborative R&D projects now open

    Funding Innovation

06.05.2025

Learn more
fellipe-ditadi-3gE3f-LbEXw-unsplash-(1)

Pitch & Match: Register now for BioWin/Flanders Vaccine joint event

    Collaboration Innovation

25.04.2025

Learn more
Innovation-Lab-newsletter

BioWin’s Innovation Lab: Got an idea? Let’s talk.

    Collaboration Innovation

16.04.2025

Learn more

Join AWEX, BioWin and WE at BioEquity Europe

    Event

11.04.2025

Learn more
BioWin COO

BioWin strengthens focus on advanced therapies and nuclear medicine

    Corporate

14.02.2025

Learn more
Biowin-new-identity

BioWin launches new website, refreshes visual identity

    Corporate

28.01.2025

Learn more
UCB2

RYSTIGGO® (rozanolixizumab) receives approval in Japan for two new administration methods as UCB begins ONWARD program for patient support

    Press release

09.05.2025

Learn more
1746667660539628

Full-Life Technologies Announces Appointment of Debora Barton, MD, as Chief Medical Officer

    Press release

08.05.2025

Learn more
Untitled-design-7-1536x973

AbolerIS Pharma Announces First Cohort Dosed in Phase 1 Study of ABO21009, a Novel Anti-CD45RC Antibody, for Rheumatoid Arthritis

    Press release

07.05.2025

Learn more
Capture d'écran 2025-04-24 114015

AbolerIS Pharma Announces Formation of Scientific Advisory Board

    Press release

24.04.2025

Learn more
Bioxodes-brain-image2

Bioxodes announces positive Phase 2a interim data for BIOX-101 in intracerebral hemorrhagic stroke patients

    Press release

24.04.2025

Learn more
Kiomedine

Aptissen and KiOmed Pharma forge a strategic alliance bringing breakthrough in Osteoarthritis Treatment

    Press release

23.04.2025

All news

Stay informed with the BioWin newsletter

Subscribe

Innovate

Why join BioWin

We help simplify the path to bringing innovative ideas to life. With nearly 20 years of hands-on collaborative innovation experience, we don’t just connect companies, research centers, hospitals, and academic institutions—we’re a true partner, offering real support at every step of the research and development process.

From shaping your project to sourcing its financing and ensuring it stays on track, that’s how we give health-tech and biopharma innovations their greatest chance of success.

Learn more
iStock-542576976

Connect

Why join BioWin

In a bid to increase opportunities for our members in terms of both collaboration and market expansion, we connect them to partners through regular events. We also seek to enhance sector attractiveness to source the future talent needed to create sustainable innovation across the Walloon Region.

 

Learn more
iStock-530685719

Communicate

Why join BioWin

Our targeted communication strategies aim to strengthen Wallonia’s profile, while maximising our members’ presence both locally and globally.

Learn more
getty-images-B1n_PGHf4JA-unsplash

Operating at the epicentre of regional health-tech & biopharma innovation

What we work on

Biopharma

iStock-1289345741

Health-tech

iStock-1125084447-web
  • From championing collaborative innovation to playing a more global role in the implementation of the sector’s industrial policy, making innovation happen is part of our DNA.
  • We aim to increase the competitiveness of the Walloon region in the biopharma and health-tech sectors by identifying and supporting strategic projects and portfolios for the benefit of our members and the patients they serve.
  • BioWin’s network of 260+ world-class organisations is an exceptional ecosystem known for both its academic excellence and robust industrial value chain in biomanufacturing, advanced therapies, nuclear medicine and medical technologies. 

Our ecosystem at a glance

Numbers

Our ecosystem

265

supported organisations

89

supported R&D projects

313,74M

€ raised by our members through public-private funding

17

job offers